These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15599675)

  • 1. [Mechanisms of inflammation in heart failure].
    Fuchs M; Drexler H
    Herz; 2004 Dec; 29(8):782-7. PubMed ID: 15599675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines and acute heart failure.
    Chen D; Assad-Kottner C; Orrego C; Torre-Amione G
    Crit Care Med; 2008 Jan; 36(1 Suppl):S9-16. PubMed ID: 18158483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuroendocrine and sympathetic nervous system in congestive heart failure.
    Ferrari R; Ceconi C; Curello S; Visioli O
    Eur Heart J; 1998 Jun; 19 Suppl F():F45-51. PubMed ID: 9651735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation in chronic heart failure.
    Parish RC; Evans JD
    Ann Pharmacother; 2008 Jul; 42(7):1002-16. PubMed ID: 18477736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of inflammation mediators in the pathogenesis of heart failure].
    Boglioni FV; Metra M; Locati M; Nodari S; Bontempi L; Garbellini M; Doni A; Peri G; Mantovani A
    Ital Heart J Suppl; 2001 Jun; 2(6):628-33. PubMed ID: 11460836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interaction of the neurohumoral and immune mechanisms of progression of myocardial damage].
    Krasnosel'skiĭ MIa; Vorob'ev PA; Tsurko VV
    Ter Arkh; 2010; 82(9):77-80. PubMed ID: 21086627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of immune inflammatory activity in chronic heart failure progress].
    Mamamtavrishvili ND; Kvirkveliia AA; Abashidze RI; Sharashidze NS; Narsiia EV
    Georgian Med News; 2008; (160-161):30-4. PubMed ID: 18711234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and chronic heart failure-potential therapeutic role of intravenous immunoglobulin.
    Aukrust P; Yndestad A; Damås JK; Gullestad L
    Autoimmun Rev; 2004 Mar; 3(3):221-7. PubMed ID: 15110235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug therapy of heart failure: an immunologic view.
    El Desoky ES
    Am J Ther; 2011 Sep; 18(5):416-25. PubMed ID: 20592661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of inflammatory cytokines and chemoattractants in the rat model of streptozotocin-induced diabetic heart failure.
    Drimal J; Knezl V; Navarova J; Nedelcevova J; Paulovicova E; Sotnikova R; Snirc V; Drimal D
    Endocr Regul; 2008 Sep; 42(4):129-35. PubMed ID: 18999900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction.
    Sciarretta S; Paneni F; Palano F; Chin D; Tocci G; Rubattu S; Volpe M
    Clin Sci (Lond); 2009 Mar; 116(6):467-77. PubMed ID: 19200056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunactivation in chronic heart failure. Inflammatory mediators].
    Genth-Zotz S; von Haehling S; Blankenberg S
    Z Kardiol; 2004; 93 Suppl 4():IV24-30. PubMed ID: 15085363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats.
    Sandmann S; Li J; Fritzenkötter C; Spormann J; Tiede K; Fischer JW; Unger T
    Blood Press; 2006; 15(2):116-28. PubMed ID: 16754275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic role of RAS blockade in chronic heart failure.
    Werner CM; Böhm M
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):167-77. PubMed ID: 19124420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of intravenous immunoglobulin in the treatment of chronic heart failure.
    Aukrust P; Yndestad A; Ueland T; Damås JK; Frøland SS; Gullestad L
    Int J Cardiol; 2006 Sep; 112(1):40-5. PubMed ID: 16893578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytokines and heart failure].
    Baumgarten G; Grohe C; Hoeft A; Knuefermann P
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Apr; 39(4):197-203. PubMed ID: 15098167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroimmunoendocrine interaction in the pathogenesis of chronic heart failure].
    Poskrebysheva AS; Grinevich VV; Smurova IuV; Shostak NA; Akmaev IG
    Usp Fiziol Nauk; 2003; 34(3):3-20. PubMed ID: 12942758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation, cytokines and anti-inflammatory therapies in heart failure.
    Tabet JY; Lopes ME; Champagne S; Su JB; Merlet P; Hittinger L
    Arch Mal Coeur Vaiss; 2002 Mar; 95(3):204-12. PubMed ID: 11998336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for activation of immune system in heart failure: is there a role for anti-inflammatory therapy?
    Celis R; Torre-Martinez G; Torre-Amione G
    Curr Opin Cardiol; 2008 May; 23(3):254-60. PubMed ID: 18382215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of immune and inflammatory systems in chronic heart failure: novel therapeutic approaches.
    Gong KZ; Song G; Spiers JP; Kelso EJ; Zhang ZG
    Int J Clin Pract; 2007 Apr; 61(4):611-21. PubMed ID: 17394435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.